• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体液免疫应答在利什曼病中的作用。

Humoral response in Leishmaniasis.

机构信息

Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.

出版信息

Front Cell Infect Microbiol. 2022 Dec 12;12:1063291. doi: 10.3389/fcimb.2022.1063291. eCollection 2022.

DOI:10.3389/fcimb.2022.1063291
PMID:36579347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9791258/
Abstract

Leishmaniasis presents different types of clinical manifestations that can be divided into cutaneous leishmaniasis and visceral leishmaniasis. The host's immune system, associated with genetic and nutritional factors, is strongly involved in the evolution of the disease or parasite escape. Humoral immunity is characterized by the production of antibodies capable of promoting neutralization, opsonization, and activation of the complement system. In this scenario, B lymphocytes produce antibodies that play an important role in Leishmania infection although neglected for a long time. Thus, relevant aspects in the establishment of Leishmania infection will be addressed, highlighting the importance of humoral immunity during the entire process of Leishmania infection.

摘要

利什曼病呈现出不同类型的临床表现,可分为皮肤利什曼病和内脏利什曼病。宿主的免疫系统与遗传和营养因素有关,它强烈参与疾病的演变或寄生虫的逃逸。体液免疫的特征是产生能够促进中和、调理和激活补体系统的抗体。在这种情况下,B 淋巴细胞产生抗体,尽管长期以来被忽视,但在利什曼虫感染中起着重要作用。因此,本文将探讨利什曼虫感染建立过程中的相关方面,强调体液免疫在整个利什曼虫感染过程中的重要性。

相似文献

1
Humoral response in Leishmaniasis.体液免疫应答在利什曼病中的作用。
Front Cell Infect Microbiol. 2022 Dec 12;12:1063291. doi: 10.3389/fcimb.2022.1063291. eCollection 2022.
2
Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.联合 L5 和 L3 利什曼原虫核糖体蛋白的基于疫苗的交叉保护作用与 Th1 佐剂在小鼠皮肤和内脏利什曼病中的作用。
Parasit Vectors. 2014 Jan 2;7:3. doi: 10.1186/1756-3305-7-3.
3
Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.硕大利什曼原虫热休克蛋白70(HSP70)在皮肤利什曼病的小鼠模型中没有保护作用,且会在皮肤利什曼病和内脏利什曼病患者中激发强烈的体液免疫反应。
Vaccine. 2007 May 22;25(21):4159-69. doi: 10.1016/j.vaccine.2007.03.006. Epub 2007 Mar 19.
4
Cellular and humoral responses induced by Leishmania histone H2B and its divergent and conserved parts in cutaneous and visceral leishmaniasis patients, respectively.分别在皮肤利什曼病和内脏利什曼病患者中诱导的利什曼原虫组蛋白 H2B 及其差异和保守部分引起的细胞和体液反应。
Vaccine. 2010 Feb 17;28(7):1881-6. doi: 10.1016/j.vaccine.2009.11.075. Epub 2009 Dec 14.
5
Evaluation of systemic immunity in atypical cutaneous leishmaniasis caused by Leishmania (L.) infantum chagasi.评估由恰加斯利什曼原虫引起的非典型皮肤利什曼病的全身免疫反应。
Parasite Immunol. 2022 Jan;44(1-2):e12896. doi: 10.1111/pim.12896. Epub 2021 Nov 17.
6
Phenotypical and genotypical differences among Leishmania (Leishmania) amazonensis isolates that caused different clinical frames in humans and dogs: A systematic review.利什曼原虫(Leishmania)亚马逊种分离株之间表型和基因型的差异,这些差异导致了人类和狗的不同临床特征:系统综述。
Acta Trop. 2021 Sep;221:106018. doi: 10.1016/j.actatropica.2021.106018. Epub 2021 Jun 19.
7
Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients.治愈的皮肤利什曼病和地中海内脏利什曼病患者对硕大利什曼原虫毒力因子的细胞和体液反应。
Clin Vaccine Immunol. 2009 Jun;16(6):956-8. doi: 10.1128/CVI.00023-09. Epub 2009 Apr 1.
8
Permissive and protective roles for neutrophils in leishmaniasis.中性粒细胞在利什曼病中的许可和保护作用。
Clin Exp Immunol. 2015 Nov;182(2):109-18. doi: 10.1111/cei.12674. Epub 2015 Aug 28.
9
Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.一种预防性杜氏利什曼原虫DNA疫苗对内脏型和皮肤型鼠利什曼病的交叉保护效力。
Infect Immun. 2005 Feb;73(2):812-9. doi: 10.1128/IAI.73.2.812-819.2005.
10
Regulation of immunity during visceral Leishmania infection.内脏利什曼原虫感染期间的免疫调节
Parasit Vectors. 2016 Mar 1;9:118. doi: 10.1186/s13071-016-1412-x.

引用本文的文献

1
Abscence of specific humoral response in three dogs with clinical leishmaniosis.三只患有临床利什曼病的犬未出现特异性体液反应。
Acta Vet Scand. 2025 Jun 8;67(1):31. doi: 10.1186/s13028-025-00814-9.
2
Comparative assessment of macrophage responses and antileishmanial efficacy in dynamic vs. Static culture systems utilizing chitosan-based formulations.利用基于壳聚糖的制剂在动态与静态培养系统中对巨噬细胞反应和抗利什曼原虫功效的比较评估。
PLoS One. 2025 Mar 11;20(3):e0319610. doi: 10.1371/journal.pone.0319610. eCollection 2025.
3
Immunoinformatic approach to the design of a novel multi-epitope vaccine against fused to human IgG-Fc.一种针对与人类IgG-Fc融合的新型多表位疫苗设计的免疫信息学方法。
Res Pharm Sci. 2024 Dec 15;19(6):729-745. doi: 10.4103/RPS.RPS_145_24. eCollection 2024 Dec.
4
Humoral and cellular immunity in response to an -designed multi-epitope recombinant protein of .针对 的基于设计的多表位重组蛋白的体液和细胞免疫反应。
Front Immunol. 2024 Aug 21;15:1400308. doi: 10.3389/fimmu.2024.1400308. eCollection 2024.
5
The non-pathogenic protozoon interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation.非致病原生动物干扰人细胞中 NLRP3 炎性小体的激活:炎症控制的新视角。
Front Immunol. 2024 Apr 19;15:1298275. doi: 10.3389/fimmu.2024.1298275. eCollection 2024.
6
The use of recombinant K39, KMP11, and crude antigen-based indirect ELISA as a serological diagnostic tool and a measure of exposure for cutaneous leishmaniasis in Sri Lanka.在斯里兰卡,使用重组 K39、KMP11 和基于粗抗原的间接 ELISA 作为血清学诊断工具和皮肤利什曼病暴露的衡量标准。
Parasitol Res. 2023 Dec 29;123(1):77. doi: 10.1007/s00436-023-08103-y.

本文引用的文献

1
Factor D.补体D因子
Immunol Rev. 2023 Jan;313(1):15-24. doi: 10.1111/imr.13155. Epub 2022 Oct 31.
2
Defective in Lipophosphoglycan Biosynthesis Interferes With Activation of Human Neutrophils.脂磷壁酸生物合成缺陷干扰人中性粒细胞的激活。
Front Cell Infect Microbiol. 2022 Apr 6;12:788196. doi: 10.3389/fcimb.2022.788196. eCollection 2022.
3
Leishmania infantum reactivation with secondary IgA nephropathy.婴儿利什曼原虫再激活伴继发性IgA肾病
J Travel Med. 2022 Nov 4;29(7). doi: 10.1093/jtm/taac038.
4
Methodological Appraisal of Literature Concerning the Analysis of Genetic Variants or Protein Levels of Complement Components on Susceptibility to Infection by Trypanosomatids: A Systematic Review.方法学评价文献关于分析补体成分的遗传变异或蛋白水平对感染锥虫易感性的影响:系统综述。
Front Immunol. 2021 Nov 25;12:780810. doi: 10.3389/fimmu.2021.780810. eCollection 2021.
5
Evasion of the complement system by Leishmania through the uptake of factor H, a complement regulatory protein.利什曼原虫通过摄取补体调节蛋白因子 H 来逃避补体系统。
Acta Trop. 2021 Dec;224:106152. doi: 10.1016/j.actatropica.2021.106152. Epub 2021 Sep 30.
6
Successful treatment of diffuse cutaneous leishmaniasis caused by Leishmania amazonensis.成功治疗由亚马逊利什曼原虫引起的皮肤弥漫性利什曼病。
An Bras Dermatol. 2021 Sep-Oct;96(5):602-604. doi: 10.1016/j.abd.2021.03.003. Epub 2021 Jul 15.
7
The lectin pathway of complement and the initial recognition of Leishmania infantum promastigotes.补体凝集素途径和利什曼原虫无鞭毛体的初始识别。
Life Sci. 2021 Oct 1;282:119793. doi: 10.1016/j.lfs.2021.119793. Epub 2021 Jul 6.
8
High Anti- IgG Antibody Levels Are Associated With Severity of Mucosal Leishmaniasis.高抗 IgG 抗体水平与黏膜利什曼病的严重程度相关。
Front Cell Infect Microbiol. 2021 Apr 9;11:652956. doi: 10.3389/fcimb.2021.652956. eCollection 2021.
9
Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines.抗锑和敏感利什曼原虫株的比较转录组分析。
Parasit Vectors. 2020 Nov 30;13(1):600. doi: 10.1186/s13071-020-04486-4.
10
How to B(e)-1 Important Cell During Infection.在感染期间如何成为重要的细胞。
Front Cell Infect Microbiol. 2020 Jan 14;9:424. doi: 10.3389/fcimb.2019.00424. eCollection 2019.